Hodnota podniku společnosti Panbela Therapeutics
Jaká je hodnota metriky Hodnota podniku společnosti Panbela Therapeutics?
Hodnota metriky Hodnota podniku společnosti Panbela Therapeutics Inc. je $9.68M
Jaká je definice metriky Hodnota podniku?
Podniková hodnota (Enterprise value) je měřítkem celkové tržní hodnoty společnosti. Vypočítává se jako tržní kapitalizace s dluhem, menšinovým podílem a přednostními akciemi sníženými o celkovou hodnotu dostupných peněz a jejich ekvivalentů.
It is a sum of claims by all claimants including creditors (secured and unsecured) and shareholders (preferred and common). Enterprise value is one of the fundamental metrics used in business valuation, financial modeling, accounting, portfolio analysis, and risk analysis. Enterprise value is more comprehensive than market capitalization, which only reflects common equity and is considered more representative of a company’s value. Enterprise value reflects the opportunistic nature of business and may change substantially over time because of both external and internal conditions.
Enterprise value can be negative if the company holds abnormally high amounts of cash that is not reflected in the market value of the stock and total capitalization. Cash is subtracted in the calculation because it reduces the net cost to a potential purchaser. The effect applies whether the cash is used to issue dividends or to pay down debt. Value of minority interest is added because it reflects the claim on assets consolidated into the firm in question. Value of associate companies is subtracted because it reflects the claim on assets consolidated into other firms. EV should also include such special components as unfunded pension liabilities, employee stock options, environmental provisions, abandonment provisions, and so on, since they also reflect claims on the company.
Hodnota podniku společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností Panbela Therapeutics
Čemu se věnuje společnost Panbela Therapeutics?
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.
Firmy s metrikou hodnota podniku podobnou společnosti Panbela Therapeutics
- Hodnota metriky Hodnota podniku společnosti Makers Laboratories je $9.66M
- Hodnota metriky Hodnota podniku společnosti Mohit Industries je $9.67M
- Hodnota metriky Hodnota podniku společnosti Peppermint Innovation je $9.67M
- Hodnota metriky Hodnota podniku společnosti Invigor je $9.67M
- Hodnota metriky Hodnota podniku společnosti Curative Biosciences je $9.68M
- Hodnota metriky Hodnota podniku společnosti Surefire Resources NL je $9.68M
- Hodnota metriky Hodnota podniku společnosti Panbela Therapeutics je $9.68M
- Hodnota metriky Hodnota podniku společnosti Oakdale Resources je $9.69M
- Hodnota metriky Hodnota podniku společnosti Viva Gold je $9.69M
- Hodnota metriky Hodnota podniku společnosti Edensoft je $9.69M
- Hodnota metriky Hodnota podniku společnosti InnovaDerma Plc je $9.69M
- Hodnota metriky Hodnota podniku společnosti General Assembly je $9.70M
- Hodnota metriky Hodnota podniku společnosti Redbank Copper je $9.71M